1
|
Szymaszek P, Tyszka-Czochara M, Ortyl J. Application of Photoactive Compounds in Cancer Theranostics: Review on Recent Trends from Photoactive Chemistry to Artificial Intelligence. Molecules 2024; 29:3164. [PMID: 38999115 PMCID: PMC11243723 DOI: 10.3390/molecules29133164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2024] [Revised: 06/14/2024] [Accepted: 06/25/2024] [Indexed: 07/14/2024] Open
Abstract
According to the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC), the number of cancer cases and deaths worldwide is predicted to nearly double by 2030, reaching 21.7 million cases and 13 million fatalities. The increase in cancer mortality is due to limitations in the diagnosis and treatment options that are currently available. The close relationship between diagnostics and medicine has made it possible for cancer patients to receive precise diagnoses and individualized care. This article discusses newly developed compounds with potential for photodynamic therapy and diagnostic applications, as well as those already in use. In addition, it discusses the use of artificial intelligence in the analysis of diagnostic images obtained using, among other things, theranostic agents.
Collapse
Affiliation(s)
- Patryk Szymaszek
- Department of Biotechnology and Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Kraków, Poland
| | | | - Joanna Ortyl
- Department of Biotechnology and Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Kraków, Poland
- Photo HiTech Ltd., Bobrzyńskiego 14, 30-348 Kraków, Poland
- Photo4Chem Ltd., Juliusza Lea 114/416A-B, 31-133 Cracow, Poland
| |
Collapse
|
2
|
Gao J, Jiang H, Chen P, Zhang R, Liu N. Photosensitizer-based small molecule theranostic agents for tumor-targeted monitoring and phototherapy. Bioorg Chem 2023; 136:106554. [PMID: 37094481 DOI: 10.1016/j.bioorg.2023.106554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Revised: 03/27/2023] [Accepted: 04/15/2023] [Indexed: 04/26/2023]
Abstract
Small molecule theranostic agents for tumor treatment exhibited triadic properties in tumor targeting, imaging, and therapy, which have attracted increasing attention as a potential complement for, or improved to, classical small molecule antitumor drugs. Photosensitizer have dual functions of imaging and phototherapy, and have been widely used in the construction of small molecule theranostic agents over the last decade. In this review, we summarized representative agents that have been studied in the field of small molecule theranostic agents based on photosensitizer in the last decade, and highlighted their characteristics and application in tumor-targeted monitoring and phototherapy. The challenges and future perspectives of photosensitizers in building small molecule theranostic agents for diagnosis and therapy of tumors were also discussed.
Collapse
Affiliation(s)
- Jiake Gao
- The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266071, China
| | - Hongfei Jiang
- The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266071, China
| | - Pengwei Chen
- Hainan Key Laboratory for Research and Development of Natural Products from Li Folk Medicine, Institute of Tropical Bioscience and Biotechnology, Chinese Academy of Tropical Agricultural Sciences, Haikou 571101, China.
| | - Renshuai Zhang
- The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266071, China.
| | - Ning Liu
- The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, 266071, China.
| |
Collapse
|
3
|
Pham TC, Nguyen VN, Choi Y, Lee S, Yoon J. Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy. Chem Rev 2021; 121:13454-13619. [PMID: 34582186 DOI: 10.1021/acs.chemrev.1c00381] [Citation(s) in RCA: 567] [Impact Index Per Article: 189.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
This review presents a robust strategy to design photosensitizers (PSs) for various species. Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the use of light combined with a light-activated chemical, referred to as a PS. Attractively, PDT is one of the alternatives to conventional cancer treatment due to its noninvasive nature, high cure rates, and low side effects. PSs play an important factor in photoinduced reactive oxygen species (ROS) generation. Although the concept of photosensitizer-based photodynamic therapy has been widely adopted for clinical trials and bioimaging, until now, to our surprise, there has been no relevant review article on rational designs of organic PSs for PDT. Furthermore, most of published review articles in PDT focused on nanomaterials and nanotechnology based on traditional PSs. Therefore, this review aimed at reporting recent strategies to develop innovative organic photosensitizers for enhanced photodynamic therapy, with each example described in detail instead of providing only a general overview, as is typically done in previous reviews of PDT, to provide intuitive, vivid, and specific insights to the readers.
Collapse
Affiliation(s)
- Thanh Chung Pham
- Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan 48513, Korea
| | - Van-Nghia Nguyen
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Korea
| | - Yeonghwan Choi
- Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan 48513, Korea
| | - Songyi Lee
- Department of Chemistry, Pukyong National University, Busan 48513, Korea.,Industry 4.0 Convergence Bionics Engineering, Pukyong National University, Busan 48513, Korea
| | - Juyoung Yoon
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Korea
| |
Collapse
|
4
|
Zhao X, Liu J, Fan J, Chao H, Peng X. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application. Chem Soc Rev 2021; 50:4185-4219. [PMID: 33527104 DOI: 10.1039/d0cs00173b] [Citation(s) in RCA: 459] [Impact Index Per Article: 153.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Photodynamic therapy (PDT), a therapeutic mode involving light triggering, has been recognized as an attractive oncotherapy treatment. However, nonnegligible challenges remain for its further clinical use, including finite tumor suppression, poor tumor targeting, and limited therapeutic depth. The photosensitizer (PS), being the most important element of PDT, plays a decisive role in PDT treatment. This review summarizes recent progress made in the development of PSs for overcoming the above challenges. This progress has included PSs developed to display enhanced tolerance of the tumor microenvironment, improved tumor-specific selectivity, and feasibility of use in deep tissue. Based on their molecular photophysical properties and design directions, the PSs are classified by parent structures, which are discussed in detail from the molecular design to application. Finally, a brief summary of current strategies for designing PSs and future perspectives are also presented. We expect the information provided in this review to spur the further design of PSs and the clinical development of PDT-mediated cancer treatments.
Collapse
Affiliation(s)
- Xueze Zhao
- State Key Laboratory of Fine Chemicals, Dalian University of Technology, 2 Linggong Road, 116024 Dalian, China.
| | | | | | | | | |
Collapse
|
5
|
Liang X, Xie Y, Wu J, Wang J, Petković M, Stepić M, Zhao J, Ma J, Mi L. Functional titanium dioxide nanoparticle conjugated with phthalocyanine and folic acid as a promising photosensitizer for targeted photodynamic therapy in vitro and in vivo. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY 2021; 215:112122. [PMID: 33433386 DOI: 10.1016/j.jphotobiol.2020.112122] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/23/2020] [Revised: 11/27/2020] [Accepted: 12/29/2020] [Indexed: 12/14/2022]
Abstract
Photodynamic therapy (PDT) is a promising cancer treatment that can be implemented using various agents. The conventional photosensitizer Al (III) phthalocyanine chloride tetrasulfonic acid (Pc) has limitations of selectivity in tumor targeting, low affinity to cancer cells, and low two-photon absorption. This study presents a novel photosensitizer FA-TiO2-Pc, which has the TiO2 nanoparticle conjugated with a tumor targeting agent of folic acid (FA), and Pc. FA-TiO2-Pc possessed high targeted photodynamic therapeutic activity and excellent biocompatibility. This promising photosensitizer showed high therapeutic drug efficiency in vitro at a low concentration dose and short incubation time under one-photon excitation (OPE). In vivo, when treated with a low dose of FA-TiO2-Pc and low light irradiation, the tumor growth was depressed in mice bearing HeLa xenograft tumors with minimal side effects. In addition, the two-photon absorption of FA-TiO2-Pc was also enhanced compared to Pc, proving that FA-TiO2-Pc system has a great potential to be used for the therapy of the folate receptor positive cancer cells in both OPE-PDT and two-photon excitation (TPE)-PDT agents.
Collapse
Affiliation(s)
- Xinyue Liang
- Department of Optical Science and Engineering, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), Shanghai Engineering Research Center of Ultra-Precision Optical Manufacturing, Green Photoelectron Platform, Fudan University, 220 Handan Road, Shanghai 200433, China
| | - Yonghui Xie
- Department of Pathology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, 26 Shengli Street, Wuhan, Hubei 430014, China
| | - Junxin Wu
- Department of Optical Science and Engineering, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), Shanghai Engineering Research Center of Ultra-Precision Optical Manufacturing, Green Photoelectron Platform, Fudan University, 220 Handan Road, Shanghai 200433, China
| | - Jing Wang
- State Key Laboratory of High Field Laser Physics, Shanghai Institute of Optics and Fine Mechanics, Chinese Academy of Sciences, 390 Qinghe Road, Shanghai 201800, China
| | - Marijana Petković
- Vinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, P.O. Box 522, 11001 Belgrade, Serbia
| | - Milutin Stepić
- Vinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, P.O. Box 522, 11001 Belgrade, Serbia
| | - Jinzhuo Zhao
- Department of Environmental Health, School of Public Health and the Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai 200032, China.
| | - Jiong Ma
- Department of Optical Science and Engineering, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), Shanghai Engineering Research Center of Ultra-Precision Optical Manufacturing, Green Photoelectron Platform, Fudan University, 220 Handan Road, Shanghai 200433, China; Institute of Biomedical Engineering and Technology, Academy for Engineer and Technology, Fudan University, 220 Handan Road, Shanghai 200433, China; Shanghai Engineering Research Center of Industrial Microorganisms, The Multiscale Research Institute of Complex Systems (MRICS), School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, China.
| | - Lan Mi
- Department of Optical Science and Engineering, Key Laboratory of Micro and Nano Photonic Structures (Ministry of Education), Shanghai Engineering Research Center of Ultra-Precision Optical Manufacturing, Green Photoelectron Platform, Fudan University, 220 Handan Road, Shanghai 200433, China.
| |
Collapse
|
6
|
Luo D, Wang X, Walker E, Wang J, Springer S, Lou J, Ramamurthy G, Burda C, Basilion JP. Nanoparticles Yield Increased Drug Uptake and Therapeutic Efficacy upon Sequential Near-Infrared Irradiation. ACS NANO 2020; 14:15193-15203. [PMID: 33090762 PMCID: PMC9109620 DOI: 10.1021/acsnano.0c05425] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
Abstract
Nanoparticles offer great opportunities for precision medicine. However, the use of nanoparticles as smart photosensitizers that target tumor biomarkers and are responsive to the tumor microenvironment has yet to be explored. Herein, prostate cancer (PCa)-selective theranostic gold nanoparticles (AuNPs) for precise cancer imaging and therapy are developed. Silicon phthalocyanine, Pc158, was synthesized and deactivated by conjugating it to AuNPs via a biocleavable linker. In vitro and in vivo, the targeted AuNPs show excellent selectivity for PSMA-positive tumor cells. Triggered release of the therapeutic, Pc158, followed by sequential photodynamic therapy (PDT) results in significant inhibition of tumor growth. Further, we demonstrate that multiple sequential PDT greatly enhances nanoparticle uptake and therapeutic efficacy. PSMA is highly expressed in the neovasculature of most other solid tumors in humans, as well as PCa, making this approach of great practical interest for precision PDT in a wide range of cancers.
Collapse
|
7
|
|
8
|
Jenni S, Sour A, Bolze F, Ventura B, Heitz V. Tumour-targeting photosensitisers for one- and two-photon activated photodynamic therapy. Org Biomol Chem 2019; 17:6585-6594. [DOI: 10.1039/c9ob00731h] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Efficient receptor-mediated delivery of a folate-targeted photosensitiser to kill cancer cells following two-photon excitation in the near-infrared is demonstrated.
Collapse
Affiliation(s)
- Sébastien Jenni
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels
- Institut de Chimie de Strasbourg UMR 7177/CNRS
- Université de Strasbourg
- 67000 Strasbourg
- France
| | - Angélique Sour
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels
- Institut de Chimie de Strasbourg UMR 7177/CNRS
- Université de Strasbourg
- 67000 Strasbourg
- France
| | - Frédéric Bolze
- CAMB
- UMR 7199
- UdS/CNRS
- Faculté de Pharmacie
- Université de Strasbourg
| | | | - Valérie Heitz
- Laboratoire de Synthèse des Assemblages Moléculaires Multifonctionnels
- Institut de Chimie de Strasbourg UMR 7177/CNRS
- Université de Strasbourg
- 67000 Strasbourg
- France
| |
Collapse
|
9
|
Bolze F, Jenni S, Sour A, Heitz V. Molecular photosensitisers for two-photon photodynamic therapy. Chem Commun (Camb) 2018; 53:12857-12877. [PMID: 29115314 DOI: 10.1039/c7cc06133a] [Citation(s) in RCA: 157] [Impact Index Per Article: 26.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Two-photon excitation has attracted the attention of biologists, especially after the development of two-photon excited microscopy in the nineties. Since then, new applications have rapidly emerged such as the release of biologically active molecules and photodynamic therapy (PDT) using two-photon excitation. PDT, which requires a light-activated drug (photosensitiser), is a clinically approved and minimally invasive treatment for cancer and for non-malignant diseases. This feature article focuses on the engineering of molecular two-photon photosensitisers for PDT, which should bring important benefits to the treatment, increase the treatment penetration depth with near-infrared light excitation, improve the spatial selectivity and reduce the photodamage to healthy tissues. After an overview of the two-photon absorption phenomenon and the methods to evaluate two-photon induced phototoxicity on cell cultures, the different classes of photosensitisers described in the literature are discussed. The two-photon PDT performed with historical one-photon sensitisers are briefly presented, followed by specifically engineered cyclic tetrapyrrole photosensitisers, purely organic photosensitisers and transition metal complexes. Finally, targeted two-photon photosensitisers and theranostic agents that should enhance the selectivity and efficiency of the treatment are discussed.
Collapse
Affiliation(s)
- F Bolze
- CAMB, UMR 7199, UdS/CNRS, Faculté de Pharmacie, Université de Strasbourg, 74 route du Rhin, 67401 Illkirch, France.
| | | | | | | |
Collapse
|
10
|
Chow SYS, Wong RCH, Zhao S, Lo PC, Ng DKP. Disulfide-Linked Dendritic Oligomeric Phthalocyanines as Glutathione-Responsive Photosensitizers for Photodynamic Therapy. Chemistry 2018; 24:5779-5789. [DOI: 10.1002/chem.201706128] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2017] [Indexed: 02/04/2023]
Affiliation(s)
- Sun Y. S. Chow
- Department of Chemistry; The Chinese University of Hong Kong; Shatin N.T. Hong Kong China
| | - Roy C. H. Wong
- Department of Chemistry; The Chinese University of Hong Kong; Shatin N.T. Hong Kong China
| | - Shirui Zhao
- Department of Chemistry; The Chinese University of Hong Kong; Shatin N.T. Hong Kong China
| | - Pui-Chi Lo
- Department of Biomedical Sciences; City University of Hong Kong; Tat Chee Avenue Kowloon Hong Kong China
| | - Dennis K. P. Ng
- Department of Chemistry; The Chinese University of Hong Kong; Shatin N.T. Hong Kong China
| |
Collapse
|
11
|
Li K, Qiu L, Liu Q, Lv G, Zhao X, Wang S, Lin J. Conjugate of biotin with silicon(IV) phthalocyanine for tumor-targeting photodynamic therapy. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY 2017; 174:243-250. [PMID: 28802175 DOI: 10.1016/j.jphotobiol.2017.08.003] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/27/2017] [Revised: 07/24/2017] [Accepted: 08/02/2017] [Indexed: 11/19/2022]
Abstract
In order to improve the efficacy of photodynamic therapy (PDT), biotin was axially conjugated with silicon(IV) phthalocyanine (SiPc) skeleton to develop a new tumor-targeting photosensitizer SiPc-biotin. The target compound SiPc-biotin showed much higher binding affinity toward BR-positive (biotin receptor overexpressed) HeLa human cervical carcinoma cells than its precursor SiPc-pip. However, when the biotin receptors of HeLa cells were blocked by free biotin, >50% uptake of SiPc-biotin was suppressed, demonstrating that SiPc-biotin could selectively accumulate in BR-positive cancer cells via the BR-mediated internalization. The confocal fluorescence images further confirmed the target binding ability of SiPc-biotin. As a consequence of specificity of SiPc-biotin toward BR-positive HeLa cells, the photodynamic effect was also largely dependent on the BR expression level of HeLa cells. The photodynamic activities of SiPc-biotin against HeLa cells were dramatically reduced when the biotin receptors were blocked by the free biotin (IC50: 0.18μM vs. 0.46μM). It is concluded that SiPc-biotin can selectively damage BR-positive cancer cells under irradiation. Furthermore, the dark toxicity of SiPc-biotin toward human normal liver cell lines LO2 was much lower than that of its precursor SiPc-pip. The targeting photodynamic activity and low dark toxicity suggest that SiPc-biotin is a promising photosensitizer for tumor-targeting photodynamic therapy.
Collapse
Affiliation(s)
- Ke Li
- Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, PR China
| | - Ling Qiu
- Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, PR China.
| | - Qingzhu Liu
- Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, PR China
| | - Gaochao Lv
- Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, PR China
| | - Xueyu Zhao
- Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, PR China
| | - Shanshan Wang
- Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, PR China
| | - Jianguo Lin
- Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, PR China.
| |
Collapse
|
12
|
Folic acid conjugates with photosensitizers for cancer targeting in photodynamic therapy: Synthesis and photophysical properties. Bioorg Med Chem 2017; 25:1-10. [DOI: 10.1016/j.bmc.2016.10.004] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2016] [Revised: 09/14/2016] [Accepted: 10/06/2016] [Indexed: 12/20/2022]
|
13
|
Luan L, Fang W, Liu W, Tian M, Ni Y, Chen X, Yu X, He J, Yang Y, Li X. 4-tert-butylphenoxy substituted phthalocyanine with RGD motif as highly selective one-photon and two-photon imaging probe for mitochondria and cancer cell. J PORPHYR PHTHALOCYA 2016. [DOI: 10.1142/s1088424616500188] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
An unsymmetrical phthalocyanine based one- and two-photon fluorescence imaging probe that substituted with 4-tert-butylphenoxy and RDGyK moieties was developed and characterized by UV-vis and high-resolution MALDI-TOF/MS. The conjugate is non-aggregated in [Formula: see text],[Formula: see text]-dimethylformamide, with relatively weak fluorescence emission ([Formula: see text] 0.023) and high singlet oxygen quantum yield ([Formula: see text] 0.55). Conjugation of the cyclic peptide sequence c(RGDyK) can enhance the cellular uptake towards the DU145 and PC3 cells. While the fluorescence is greatly enhanced in mitochondria, the conjugate is non-cytotoxicity either in dark or upon exposure to red-light with dose up to 12 J.cm[Formula: see text]. The results suggest that this conjugate is a promising multifunctional imaging probe for mitochondria and cancer.
Collapse
Affiliation(s)
- Liqiang Luan
- State Key Laboratory of Crystal Materials, Shandong University, Jinan 250012, P.R. China
| | - Wenjuan Fang
- State Key Laboratory of Crystal Materials, Shandong University, Jinan 250012, P.R. China
| | - Wei Liu
- State Key Laboratory of Crystal Materials, Shandong University, Jinan 250012, P.R. China
| | - Minggang Tian
- State Key Laboratory of Crystal Materials, Shandong University, Jinan 250012, P.R. China
| | - Yuxing Ni
- State Key Laboratory of Crystal Materials, Shandong University, Jinan 250012, P.R. China
| | - Xi Chen
- State Key Laboratory of Crystal Materials, Shandong University, Jinan 250012, P.R. China
| | - Xiaoqiang Yu
- State Key Laboratory of Crystal Materials, Shandong University, Jinan 250012, P.R. China
| | - Jing He
- School of Medicine, Shandong University, Jinan 250012, P.R. China
| | - Yang Yang
- School of Medicine, Shandong University, Jinan 250012, P.R. China
| | - Xiangzhi Li
- School of Medicine, Shandong University, Jinan 250012, P.R. China
| |
Collapse
|
14
|
Li Y, Wang J, Zhang X, Guo W, Li F, Yu M, Kong X, Wu W, Hong Z. Highly water-soluble and tumor-targeted photosensitizers for photodynamic therapy. Org Biomol Chem 2016; 13:7681-94. [PMID: 26082999 DOI: 10.1039/c5ob01035g] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
Biological uses of photosensitizers in photodynamic therapy (PDT) often suffer from a lack of tumor selectivity; a strategy based on molecule-targeted cancer therapies could provide a promising solution. To synthesize new water-soluble phthalocyanines (Pcs) for bio-conjugation with peptides or antibodies, we developed a method to synthesize asymmetrically substituted Pcs with both high water solubility and one monoamino group for conjugation with biological agents for tumor homing, using folic acid as the ligand model to direct the modified Pcs into target cells. Here, we report studies on the syntheses and characterization of these Pcs. In vitro and in vivo assays prove that the high solubility characteristic can greatly increase the tumor targeting capability of Pcs by reducing non-specific uptake. This newly designed photosensitizer accumulated almost completely in tumor regions, with a negligible signal found in other tissues in the xenograft tumor model. These initial data provide strong evidence of the high specificity tumor targeting of Pcs with folate and tri-glycerol substitutions. Theoretically, the synthesized Pcs could be conveniently conjugated to many other ligands, endorsing the broad applicability of this method for tumor-targeted PDT.
Collapse
Affiliation(s)
- Yuxi Li
- College of Material Science and Chemical Engineering, Tianjin University of Science and Technology, Tianjin 300457, P. R. China.
| | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Luan L, Fang W, Liu W, Tian M, Ni Y, Chen X, Yu X. Phthalocyanine-cRGD conjugate: synthesis, photophysical properties and in vitro biological activity for targeting photodynamic therapy. Org Biomol Chem 2016; 14:2985-92. [DOI: 10.1039/c6ob00099a] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Phthalocyanine-RGD conjugate was synthesized and examined for its two-photon absorption cross section (TPACS), cellular uptake, and photocytotoxicity.
Collapse
Affiliation(s)
- Liqiang Luan
- State Key Laboratory of Crystal Materials
- Shandong University
- Jinan 250012
- P.R. China
| | - Wenjuan Fang
- State Key Laboratory of Crystal Materials
- Shandong University
- Jinan 250012
- P.R. China
| | - Wei Liu
- State Key Laboratory of Crystal Materials
- Shandong University
- Jinan 250012
- P.R. China
| | - Minggang Tian
- State Key Laboratory of Crystal Materials
- Shandong University
- Jinan 250012
- P.R. China
| | - Yuxing Ni
- State Key Laboratory of Crystal Materials
- Shandong University
- Jinan 250012
- P.R. China
| | - Xi Chen
- State Key Laboratory of Crystal Materials
- Shandong University
- Jinan 250012
- P.R. China
| | - Xiaoqiang Yu
- State Key Laboratory of Crystal Materials
- Shandong University
- Jinan 250012
- P.R. China
| |
Collapse
|
16
|
Yang S, Yang X, Liu Y, Zheng B, Meng L, Lee RJ, Xie J, Teng L. Non-covalent complexes of folic acid and oleic acid conjugated polyethylenimine: An efficient vehicle for antisense oligonucleotide delivery. Colloids Surf B Biointerfaces 2015; 135:274-282. [PMID: 26263216 PMCID: PMC4856292 DOI: 10.1016/j.colsurfb.2015.07.047] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2015] [Revised: 07/09/2015] [Accepted: 07/19/2015] [Indexed: 10/23/2022]
Abstract
Polyethylenimine (PEI) was conjugated to oleic acid (PEI-OA) and evaluated as a delivery agent for LOR-2501, an antisense oligonucleotide against ribonucleotide reductase R1 subunit. PEI-OA/LOR-2501 complexes were further coated with folic acid (FA/PEI-OA/LOR-2501) and evaluated in tumor cells. The level of cellular uptake of FA/PEI-OA/LOR-2501 was more than double that of PEI/LOR-2501 complexes, and was not affected by the expression level of folate receptor (FR) on the cell surface. Efficient delivery was seen in several cell lines. Furthermore, pathway specific cellular internalization inhibitors and markers were used to reveal the principal mechanism of cellular uptake. FA/PEI-OA/LOR-2501 significantly induced the downregulation of R1 mRNA and R1 protein. This novel formulation of FA/PEI-OA provides a reliable and highly efficient method for delivery of oligonucleotide and warrants further investigation.
Collapse
Affiliation(s)
- Shuang Yang
- College of Life Sciences, Jilin University, Changchun 130012, China
| | - Xuewei Yang
- College of Life Sciences, Jilin University, Changchun 130012, China
| | - Yan Liu
- College of Life Sciences, Jilin University, Changchun 130012, China
| | - Bin Zheng
- College of Life Sciences, Jilin University, Changchun 130012, China
| | - Lingjun Meng
- College of Life Sciences, Jilin University, Changchun 130012, China
| | - Robert J Lee
- College of Life Sciences, Jilin University, Changchun 130012, China; College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA
| | - Jing Xie
- College of Life Sciences, Jilin University, Changchun 130012, China.
| | - Lesheng Teng
- College of Life Sciences, Jilin University, Changchun 130012, China; State Key Laboratory of Long-acting and Targeting Drug Delivery System, Yantai 264000, China.
| |
Collapse
|
17
|
Solid phase synthesis of a novel folate-conjugated 5-aminolevulinic acid methyl ester based photosensitizer for selective photodynamic therapy. Tetrahedron Lett 2015. [DOI: 10.1016/j.tetlet.2014.12.028] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
18
|
Doshi M, Krienke M, Khederzadeh S, Sanchez H, Copik A, Oyer J, Gesquiere AJ. Conducting polymer nanoparticles for targeted cancer therapy. RSC Adv 2015. [DOI: 10.1039/c5ra05125h] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Functionalized conducting polymer nanoparticles allow for targeted delivery, tracking by fluorescence bioimaging, and therapeutics through formation of reactive oxygen species.
Collapse
Affiliation(s)
- Mona Doshi
- NanoScience Technology Center
- University of Central Florida
- Orlando
- USA
- Department of Chemistry
| | - Marissa Krienke
- NanoScience Technology Center
- University of Central Florida
- Orlando
- USA
- Department of Biology
| | - Saeid Khederzadeh
- NanoScience Technology Center
- University of Central Florida
- Orlando
- USA
- Department of Materials Science and Engineering
| | - Henry Sanchez
- NanoScience Technology Center
- University of Central Florida
- Orlando
- USA
- Department of Materials Science and Engineering
| | - Alicja Copik
- Burnett School of Biomedical Sciences
- College of Medicine
- University of Central Florida
- Orlando
- USA
| | - Jeremiah Oyer
- Burnett School of Biomedical Sciences
- College of Medicine
- University of Central Florida
- Orlando
- USA
| | - Andre J. Gesquiere
- NanoScience Technology Center
- University of Central Florida
- Orlando
- USA
- Department of Chemistry
| |
Collapse
|
19
|
Tarakci DK, Berber S, Zorlu Y, Atilla D, Ahsen V, Dumoulin F. The synthesis of an octasubstituted monohydroxylated phthalocyanine designed to investigate the effect of the presence of active moieties. NEW J CHEM 2015. [DOI: 10.1039/c5nj00229j] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Filling a lack: monofunctionalized octasubstitution, the missing substitution pattern of phthalocyanines.
Collapse
Affiliation(s)
- Deniz Kutlu Tarakci
- Gebze Technical University
- Department of Chemistry
- 41400 Kocaeli
- Turkey
- Yıldız Technical University
| | - Savaş Berber
- Gebze Technical University
- Department of Physics
- 41400 Kocaeli
- Turkey
| | - Yunus Zorlu
- Gebze Technical University
- Department of Chemistry
- 41400 Kocaeli
- Turkey
| | - Devrim Atilla
- Gebze Technical University
- Department of Chemistry
- 41400 Kocaeli
- Turkey
| | - Vefa Ahsen
- Gebze Technical University
- Department of Chemistry
- 41400 Kocaeli
- Turkey
| | - Fabienne Dumoulin
- Gebze Technical University
- Department of Chemistry
- 41400 Kocaeli
- Turkey
| |
Collapse
|
20
|
Phthalocyanine-based photosensitizers: more efficient photodynamic therapy? Future Med Chem 2014; 6:1991-3. [DOI: 10.4155/fmc.14.139] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
|
21
|
Goswami S, Wicks G, Rebane A, Schanze KS. Photophysics and non-linear absorption of Au(i) and Pt(ii) acetylide complexes of a thienyl-carbazole chromophore. Dalton Trans 2014; 43:17721-8. [DOI: 10.1039/c4dt02123a] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
22
|
Kim J, Tung CH, Choi Y. Smart dual-functional warhead for folate receptor-specific activatable imaging and photodynamic therapy. Chem Commun (Camb) 2014; 50:10600-3. [DOI: 10.1039/c4cc04166f] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Folic acid as a bi-functional warhead to develop smart dual-targeted theranostic agents.
Collapse
Affiliation(s)
- Jisu Kim
- Molecular Imaging & Therapy Branch
- National Cancer Center
- Goyang-si, Korea
| | - Ching-Hsuan Tung
- Molecular Imaging Innovations Institute
- Department of Radiology
- Weil Cornell Medical College
- New York, USA
| | - Yongdoo Choi
- Molecular Imaging & Therapy Branch
- National Cancer Center
- Goyang-si, Korea
| |
Collapse
|